by Madaline Spencer | Feb 4, 2025
Carolina Schinke, MD, University of Arkansas for Medical Sciences, discusses differences in clinical outcomes of black patients with multiple myeloma treated with talquetamab. Multiple myeloma is a bone marrow-based plasma cell neoplasm characterized by...
by Madaline Spencer | Jan 22, 2025
David J. Kuter, MD, DPhil, discusses the latest results regarding immune thrombocytopenia (ITP) presented at ASH 2024. ITP is an autoimmune bleeding disorder characterized by too few platelets in the blood. Symptoms may include bruising, nosebleed or...
by Madaline Spencer | Jan 17, 2025
Nora Sandorfi, MD, Professor of Clinical Medicine, Rheumatology at the University of Pennsylvania, discusses patient sentiments regarding treatment options for warm autoimmune hemolytic anemia (wAIHA). wAIHA is a rare, autoimmune disorder in which...
by Madaline Spencer | Jan 14, 2025
Madelyn Schloss, Social Media and Development Associate for Gaucher Community Alliance, discusses the organization. The Gaucher Community Alliance is a non-profit organization run by patients with Gaucher disease, offering advocacy, education, patient...
by Madaline Spencer | Jan 7, 2025
Ozlem Goker-Alpan, MD, Founder and Chief Medical Officer of the Lysosomal & Rare Disorders Research & Treatment Center (LDRTC), discusses her work in lysosomal storage diseases and the GRIDS conference. Lysosomal diseases are a group of rare...
